Nanjing Vazyme Biotech Co., Ltd. (688105)
Market Open
15 Oct, 06:57 AM
SSE SSE Primary ¥
22. 37
-1.19
-5.0509%
¥
9.04B Market Cap
- P/E Ratio
0.4% Div Yield
10.69M Volume
- Eps
¥ 23.56
Previous Close Want to track 688105 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nanjing Vazyme Biotech Co., Ltd. (688105) Statistics
Valuation metrics
Market Cap 9.04B
Enterprise value 14B
Trailing P/E (ttm) 5,111,285,337,090,355,200
Forward P/E -
PEG ratio 19,760,014,837,217,224
Price/Sales (ttm) 9.34
Price/Book (mrq) 1.38
Enterprise Value/Revenue 9.51
Enterprise Value/EBITDA 142.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 20.47M
Average volume (90 days) 13.95M
Price summary
52-Week low 12.89
52-Week high 29.16
Beta -
50-Day moving average 22.5
200-Day moving average 19.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.5
Trailing annual dividend yield 0.0188%
5-Year annual dividend yield -
Payout ratio -23.05
Dividend Date 3 Jun 2026
Ex-Dividend Date 3 Jun 2026
Last split factor 1:1
Last split Date 3 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.01%
Operating margin -0.02%
Operational effectiveness
Return on assets -0%
Return on equity -0%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 7.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.38
Total debt (mrq) -
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 3.99%
Book value per share (mrq) 19.19
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
